This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
24 Mar 2011

Investigators See Promise in Stem Cell Therapy for MS

Over 11 years tracking results, 16 of those patients experienced a significant improvement for two years on their scorecard for symptoms of the disease.

A long-term research of 35 people suffering from the most aggressive version of multiple sclerosis has underscored the potential of a radical new stem cell treatment approach.

 

In the study, chemotherapy was used to eliminate all of a patient's blood cells, including the errant immune cells that trigger MS. Enriched bone marrow stem cells were transplanted back into the patients in the hope that it would "reboot" their immune system and moderate the disease.

 

Related News